Currently out of the existing stock ratings of Ben Haynor, 118 are a BUY (86.76%), 18 are a HOLD (13.24%).

Ben Haynor

Work Performance Price Targets & Ratings Chart

Analyst Ben Haynor, currently employed at LAKE STREET, carries an average stock price target met ratio of 50.02% that have a potential upside of 44.6% achieved within 252 days.

Ben Haynor’s has documented 251 price targets and ratings displayed on 33 stocks. The coverage is on Healthcare, Technology, Basic Materials, Industrials sectors.

Most recent stock forecast was given on SRTS, Sensus Healthcare at 14-Aug-2026.

Wall Street Analyst Ben Haynor

Analyst best performing recommendations are on EKSO (EKSO BIONICS HOLDINGS).
The best stock recommendation documented was for DRIO (DARIOHEALTH CORP) at 8/17/2021. The price target of $255 was fulfilled within 10 days with a profit of $43.8 (20.74%) receiving and performance score of 20.74.

Average potential price target upside

of $113.9 (25.33%) on DRIO (DARIOHEALTH CORP).
of $39.38 (59.9%) on MOTS (MOTUS GI HOLDINGS).
of $34.65 (92.88%) on IMAC (IMAC HOLDINGS).

DRIO DarioHealth Corp EYEG AB Corporate Bond ETF HSKA Heska ICCM Icecure Medical IMAC Imac Holdings KIN Kindred Biosciences MYO Myomo OPGN OpGen PROF Profound Medical Corp RSLS ReShape Lifesciences TTOO T2 Biosystms PODD Insulet KPRX Kiora Pharmaceuticals MOTS Motus GI Holdings VIVE Viveve Medical SRTS Sensus Healthcare ITMR Itamar Medical Ltd NSPR InspireMD BEAT Heartbeam BIOC Biocept EKSO Ekso Bionics Holdings BFLY Butterfly Network TCMD Tactile Systems Technology TMCI Treace Medical Concepts KIDS Orthopediatrics Corp PIII P3 Health Partners ATEC Alphatec Holdings IT Gartner RS Reliance Steel & Aluminum Co TT Trane Technologies plc VIV Telefonica Brasil SA ADR VSAT ViaSat NMTC Neuroone Medical Technologies Corp

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Charles Rhyee (TD COWEN)

Hold Since 13-Aug-2025

$0.51 (6.81%)

Please subscribe to see extended stock data

David Grossman (STIFEL)

Buy Since 22-Mar-2021

$500

Please subscribe to see extended stock data

Ben Haynor (ALLIANCE GLOBAL PARTNERS)

Buy Since 14-May-2022

Please subscribe to see extended stock data

Alexander Nowak (CRAIG HALLUM)

Buy Since 06-Jun-2019

$540

Please subscribe to see extended stock data

Nathan Weinstein (CITI)

Buy Since 17-Aug-2020

$500

Please subscribe to see extended stock data

Show more analysts

Please expand the browser size to see the chart

Which stock is Ben Haynor is most bullish on?

Potential upside of $3.69 has been obtained for PIII (P3 HEALTH PARTNERS)

Which stock is Ben Haynor is most reserved on?

Potential downside of $0.66 has been obtained for SRTS (SENSUS HEALTHCARE)

What Year was the first public recommendation made by Ben Haynor?

On 2012